Literature DB >> 12865482

Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging.

Debra L Waters1, C Lillian Yau, George D Montoya, Richard N Baumgartner.   

Abstract

BACKGROUND: Endogenous and exogenous sex hormones affect changes in body composition during aging via independent and dependent effects on the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis and associated binding proteins (BP).
METHODS: Fasting serum IGF-1, IGFBP3, testosterone, estrone, and sex hormone binding globulin were analyzed in 48 women on hormone replacement (HRT) (unopposed oral estrogen, HRT+, 74.0 +/- 6 years), 135 women not on HRT (HRT-, 77.3 +/- 7 years), and 128 healthy men (men, ). Total lean body mass (LBM) and total fat were measured by dual energy X-ray absorptiometry.
RESULTS: Total LBM decreased with age in all groups (p = .05). LBM was greater, and IGF-1, IGFBP3, and testosterone were lower in HRT+ versus HRT- women (p = .02, p = .01, p = .04, and, respectively). LBM in men was positively related to IGF-1 (p = .02) and testosterone (p < .01), whereas LBM was associated with IGFBP3 (p = .04) and total fat (p < .001) in female HRT+ and total fat (p < .01) in HRT- women. IGF-1 decreased with age in men and HRT- women (p < .01) but did not decrease in HRT+ women. Total fat significantly decreased across age (p < .05). Controlling for age and HRT, the rate of decrease in fat was slower in men versus women (p = .02). IGFBP3 decreased in all groups across age (p < .01), and the ratio of IGF-1 to IGFBP3 decreased faster in men compared to HRT+ and HRT- women (p = .02).
CONCLUSIONS: Our data indicate divergent influences of sex steroids, IGF-1, and IGFBP3 on age-related changes in LBM in healthy elderly men and women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865482     DOI: 10.1093/gerona/58.7.m648

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  16 in total

Review 1.  Ageing, growth hormone and physical performance.

Authors:  F Lanfranco; L Gianotti; R Giordano; M Pellegrino; M Maccario; E Arvat
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 2.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

3.  Knee extensor strength is associated with Mini-Mental State Examination scores in elderly men.

Authors:  Hiroki Nakamoto; Yasuhide Yoshitake; Yohei Takai; Hiroaki Kanehisa; Takahiro Kitamura; Masashi Kawanishi; Shiro Mori
Journal:  Eur J Appl Physiol       Date:  2011-09-20       Impact factor: 3.078

4.  The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1.

Authors:  Amutha Selvamani; Farida Sohrabji
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

Review 5.  Sex differences in stroke therapies.

Authors:  Farida Sohrabji; Min Jung Park; Amanda H Mahnke
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

6.  Sarcopenia: An emphasis on occlusion training and dietary protein.

Authors:  J P Loenneke; T J Pujol
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

7.  Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation.

Authors:  Kevin C Johnson; Devin C Koestler; Chao Cheng; Brock C Christensen
Journal:  Epigenetics       Date:  2013-11-06       Impact factor: 4.528

Review 8.  Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia.

Authors:  F Sohrabji; M Williams
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 9.  Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study.

Authors:  Farida Sohrabji
Journal:  Front Neuroendocrinol       Date:  2014-05-29       Impact factor: 8.606

10.  Vitamin D status, body composition and glycemic control in an ambulatory population with diabetes and chronic kidney disease.

Authors:  M R Hoffmann; P A Senior; S T Jackson; K Jindal; D R Mager
Journal:  Eur J Clin Nutr       Date:  2015-11-04       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.